Despite assurances from President Donald Trump’s administration in January that the coronavirus outbreak in the country is under control, new COVID cases in the country continued to rise. In fact, the U.S. is now the leading country in terms of the number of confirmed infections after surpassing China and Italy last week.
The recent development did not escape Hillary Clinton who has been consistently critical of President Donald Trump’s handling of the coronavirus pandemic. On Friday, the former Secretary of State took to Twitter mocking her former campaign rival and linking his “America First” slogan to the current top spot the U.S. occupies in terms of COVID-19 cases, according to Newsweek.
“He did promise ‘America First,’” Clinton tweeted. She also shared a New York Times article that reported how the U.S. became the country hardest hit by the coronavirus pandemic on Thursday.
There are now more than 150 thousand people confirmed to be infected with the virus in the U.S. There are now more than 2,800 reported deaths due to the virus.
Trump used the “America First” slogan during his 2016 campaign against Clinton. “We assembled here today are issuing a new decree to be heard in every city, in every foreign capital, and in every hall of power,” Trump said in his January 2017 inaugural address. “From this day forward, a new vision will govern our land. From this moment on, it's going to be America First.”
Clinton also criticized Trump for contradicting medical experts. “A month ago, Trump said: ‘It’s going to disappear. One day, it’s like a miracle, it will disappear,’” she wrote on a different post. “Yesterday, he said: ‘I don’t believe you need 40,000 or 30,000 ventilators.’ What will it take to get @realdonaldtrump to listen to experts instead of his own hunches?”
The former Secretary of State also criticized Trump’s response to the pandemic. “The Trump administration was told in January that coronavirus was likely to become a pandemic,” she wrote in a tweet last week. “They refused to act for fear of spooking the markets, losing weeks of time to prepare that we won't get back.”


Trump Presses Japan to Support Iran War Effort, Cites Pearl Harbor in Surprise Defense
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Ukraine-U.S. Peace Talks Continue in Florida as Zelenskiy Pushes for Diplomatic Progress
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Robert Mueller, Former FBI Director and Special Counsel, Dies at 81
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Trump Signals U.S. Nearing End of Military Goals in Iran War, Shifts Hormuz Responsibility to Regional Nations
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Ukraine-U.S. Peace Talks in Florida Target Ceasefire Framework and Defense Cooperation
Federal Judge Blocks Pentagon's Restrictive Press Access Policy 



